Harrison Seth Loring — SEC Form 4 filings
SEC reporting owner CIK 1404955. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-17.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-06-07 to 2026-07-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 30.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Stoke Therapeutics, Inc. (STOK) | Director | 4 | — | — | 19 |
| Akero Therapeutics, Inc. (AKRO) | Director | 3 | — | — | 11 |
Form 4 filings — Harrison Seth Loring
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-17 | 4 | Stoke Therapeutics, Inc. (STOK) | Gift (G): 29,555 (derivative) @ $0 · Gift (G): 29,555 (derivative) @ $0 · Gift (G): 14,777 (derivative) @ $0 · Gift (G): 14,777 (derivative) @ $0 · Gift (G): 11,650 (derivative) @ $0 · Gift (G): 11,650 (derivative) @ $0 · +10 more | EDGAR |
| 2026-06-05 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 17,786 (derivative) @ $0 | EDGAR |
| 2025-12-09 | 4 | Akero Therapeutics, Inc. (AKRO) | Disposition to issuer (D): 136,301 · Disposition to issuer (D): 148,063 · Disposition to issuer (D): 9,398 · Disposition to issuer (D): 26,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · Disposition to issuer (D): 15,000 (derivative) · +3 more | EDGAR |
| 2025-06-05 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 9,398 @ $0 | EDGAR |
| 2025-06-04 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 29,747 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Akero Therapeutics, Inc. (AKRO) | Grant/award (A): 26,000 (derivative) @ $0 | EDGAR |
| 2024-06-07 | 4 | Stoke Therapeutics, Inc. (STOK) | Grant/award (A): 7,639 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1404955 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →